ment from EGC is low, and involved lymph nodes are fundamentally confi ned to the perigastric area [7] [8] [9] . Therefore, Japanese surgeons have re-evaluated the treatment strategy of exclusive radical D2 gastrectomy for EGC and focused on function-preserving gastrectomy to attenuate postoperative symptoms such as weight loss, dumping syndrome, and residual gastritis caused by bile refl ux, these being well known as frequent problems after subtotal gastrectomy.
ment from EGC is low, and involved lymph nodes are fundamentally confi ned to the perigastric area [7] [8] [9] . Therefore, Japanese surgeons have re-evaluated the treatment strategy of exclusive radical D2 gastrectomy for EGC and focused on function-preserving gastrectomy to attenuate postoperative symptoms such as weight loss, dumping syndrome, and residual gastritis caused by bile refl ux, these being well known as frequent problems after subtotal gastrectomy.
Pylorus-preserving gastrectomy (PPG) is a modifi ed distal gastrectomy for the treatment of gastric ulcers, designed by Maki et al. [10] in 1967 as a functionpreserving procedure. PPG is aimed at maintaining stomach capacity and reducing the amount of regurgitated duodenal juice by preserving the pyloric antrum. A limited lymph node dissection, as performed in the PPG operation, was shown to be a suffi ciently safe and effective treatment for EGC by Kodama and Koyama in 1991 [11] . Since 1995, we have actively utilized PPG for the treatment of EGC in the middle body to minimize postoperative dysfunction in patients. Our recent study also showed the safety and radicality of PPG as a standard operation for EGC located in the middle body [12] . We have also reported that, as shown by the longterm follow-up results, PPG has clear advantages over distal gastrectomy with Billroth-I reconstruction, in terms of postoperative symptoms and functional outcomes [13] .
Initially, the length of the preserved pyloric cuff was 1.5 cm, as Maki et al. noted in the original article describing PPG [10] . Subsequently, Nakane et al. [14] reported that PPG with the transection of 2.5 cm proximal to the pyloric ring was superior to that with the transection of 1.5 cm in terms of some postoperative symptoms and weight recovery. Recently, Nunobe et al. [15] showed the low frequency of gastric stasis in patients with a 3-cm length of pyloric cuff. Thus, in clinical practice, the length of the preserved pyloric cuff has tended to be increased, compared to that in the initial setting. By
Introduction
A subtotal gastrectomy with D2 lymph node dissection has been the standard operation for early gastric cancer (EGC) located in the gastric middle body [1, 2] . Patients with EGC have an excellent prognosis after surgical treatment, with 5-year survival rates being in excess of 90% [1] [2] [3] [4] [5] [6] [7] . In addition, the incidence of nodal involve-sparing the infrapyloric vessels, we have been able to preserve even longer pyloric cuffs in procedures performed at the National Cancer Center Hospital.
Against this background, we investigated the relationship between the length of the pyloric cuff and postoperative complications. We also assessed whether cuff length was associated with any differences in long-term symptoms more than 3 years' postoperatively, using questionnaires.
Patients and methods

Subjects
Between 1995 and 2003, 520 patients with apparent EGC underwent PPG with lymph node dissection and routine preservation of the suprapyloric area, the vagal nerve, the fi rst branch of the right gastric artery, the pyloric sphincter, the celiac branch, and the infrapyloric vessels, as described previously [12] . During these operations, station No. 5 nodes are regularly inspected to exclude patients with gross metastasis (enlarged and/or hard nodes) in this region.
Thirty-four patients were excluded from the present study because of metachronous cancer. Four patients were excluded because of peritoneal and liver metastases. Fourteen patients died of other organ cancers or other causes and were also excluded. Three patients were excluded because additional gastrectomy was performed for residual cancers. One patient was excluded because he was followed up in other hospitals, two were excluded because of follow up at another division, and two were excluded because of mental illness. Four patients were excluded because of missing data. Thus, a total of 456 patients were enrolled in this study.
Questionnaires identifying postoperative symptoms were sent to the 456 patients after more than 3 years from the operation date. The response rate was 89.5%. Data from a total of 408 patients were analyzed. These patients were divided into two groups based on the lengths of their preserved pyloric cuffs (Fig. 1) . Of the 408 patients, 300 had a relatively short preserved pyloric cuff (within 3.0 cm; group A) and 108 had a relatively long pyloric cuff (more than 3.0 cm; group B).
Methods
Surgical specimens were examined and scored according to the Japanese classifi cation of gastric carcinoma [16] . Medical records were reviewed for further histological and follow-up data. Long-term symptoms were assessed using the diagnostic criteria established by the Japanese Society of Gastroenterological Surgery and a postal survey. The questionnaire included a total of 38 items and was composed of four scales: evaluating early dumping symptoms (18 items), late dumping symptoms (5 items), emptying disturbances (9 items), and other data (6 items) such as oral intake, bowel movements, current weight, and satisfaction rate (Table 1) . A higher mean value on the symptom scales corresponded to a higher symptomatology (0, "not at all"; 1, "occasionally"; 2, "quite often"). The incidence of grade 2 symptoms was calculated. The patients underwent a gasNo. of patients trointestinal endoscopy examination at least once within 2 years after surgery. The postoperative state of the remnant stomach was evaluated more than 3 years postoperatively using the Residue, Gastritis, Bile (RGB) classifi cation [17] . The incidences of refl ux esophagitis with a Los Angeles classifi cation of B or greater, remnant gastritis and residual food of grade 2 or greater, and bile refl ux of grade 1 were regarded as meaningful fi ndings. Unexamined patients and patients with missing data were excluded to calculate the incidence. An abdominal ultrasonography scan was performed more than 1 year after the operation. Patients with or without cholelithiasis were examined. Patients who underwent a cholecystectomy either preoperatively or intraoperatively were excluded for the calculations of incidence.
Data analysis
Statistical analyses were performed using SPSS 14.0 software (SPSS, Chicago, IL, USA). Clinicopathological fi ndings in the two groups were compared by using t-tests, the Mann-Whitney U-test, the χ 2 test, and Fisher's exact test. Differences were considered significant at P < 0.05. 
Results
Patient characteristics and clinicopathological variables
The baseline patient characteristics are summarized in Table 2 . Questionnaires completed by 408 patients (mean age, 57.1 years; range, 27 to 86 years) were available for analysis. There was no age difference (mean ages of 56.6 and 58.7 years for groups A and B, respectively; P = 0.087). But the two groups differed in sex ratios. Half of the patients in group B were male, while group A was predominantly male (64%; P = 0.013). The body mass index was around 23 in both groups.
As for the microscopic fi ndings of the resected specimens, 388 (95.1%) were confi rmed to have EGCs (mucosa, 241; submucosa, 147) and 20 (4.9%) were found to have more advanced tumors (muscularis propria, 14; subserosa, 6). Our data showed that the overall incidence of nodal involvement in all patients was 9.3% (38 patients). No differences in the distribution of the pathological depth of invasion and lymph node metastasis were observed between the two groups.
Early outcomes (Table 3) The operation time was signifi cantly longer for group B than for group A. Both groups had few complications, with the exception of gastric stasis that had severe symptoms requiring fasting and intravenous fl uid support. Gastric stasis was observed in 30 of the 300 patients in group A (10%) and in 8 of the 108 patients in group B (7.4%). No difference in the incidence of postoperative complications was observed. No mortalities occurred in either group.
Late outcomes (Tables 4, 5)
The incidence of dumping symptoms was low in both groups, especially in the late phase. On the other hand, emptying disturbances, including early satiety, a "heavy" sensation in the stomach, eructation, abdominal distention, and heartburn, were relatively frequent, occurring in approximately 6%-11% of the patients. No significant differences in the questionnaire responses were observed between the two groups. The mean relative body weight (current body weight/preoperative body Values in parentheses are percentages, unless otherwise specifi ed a Mean ± SD weight [%]) was also similar in the two groups (92.9 % in group A and 91.7 % in group B). The patient satisfaction level was also not signifi cantly different between the groups. The number of patients who were dissatisfi ed with the treatment was 6 (2.0%) in group A and 1 (1.0%) in group B. As regards postoperative oral intake tolerated per meal, compared with normal, no change was reported by 33.2% of the patients in group A and 22.2% of the patients in group B. A postoperative intake of 50% or greater than the normal volume was reported by 54.6% of the patients in group A and 62.0% of the patients in group B. An intake of 50% or less than the normal volume was reported by 12.2% of the patients in group A and 15.7% of the patients in group B. This difference was not signifi cant (P = 0.096). Both groups reported similar outcomes with regard to bowel movements and frequent fl atus. (Table 6) No signifi cant differences in esophagitis, remnant gastritis, residual food, or bile refl ux were observed between groups A and B.
Endoscopic fi ndings
Abdominal ultrasound fi ndings in the gallbladder
Ultrasound fi ndings showed no signifi cant difference in the incidence of postoperative cholelithiasis. This condition was seen in 9.1% (22/242) in group A, compared with 8.4% (7/83) in group B.
Discussion
Among the limited options for the surgical treatment of EGC, PPG is the only one to have been proven to provide satisfactory digestive function [12, 13] according to the Japanese Gastric Cancer Association Guidelines for treatment of gastric cancer [18] . While PPG has several additional benefi ts, such as the prevention of dumping syndrome, regaining of weight, maintenance of pancreatic secretory function, prevention of duodenal juice refl ux, and a low incidence of gallstones [19] [20] [21] [22] , it leads to the development of the characteristic postoperative symptom of delayed gastric emptying, at a constant rate [20, 21] .
With regard to early outcomes in the present study, the length of the pyloric cuff infl uenced the operation time (Table 3) , because preserving the infrapyloric vessels requires a meticulous operative technique based on thorough anatomical knowledge of the region surrounding the infrapyloric area. Our results also showed an extremely low incidence of postoperative complications, with the exception of gastric stasis. Gastric stasis, or emptying disturbance, is the most common complaint after PPG in the immediate postoperative period. One reason for the gastric stasis is the division of the antral intramural nerves, as described by Holle et al. [23] . Impaired circulation around the retained antrum, possibly as a result of anastomotic edema, might be another contributing factor [24] . Although a multivariate analysis did not show any signifi cant differences between our two groups, the preservation of the infrapyloric vessels, which supply and drain the pyloric antrum, may be more important when the distal transection line is set further away from the pylorus ring.
No difference was seen between our two groups with regard to late outcome (Tables 4, 5). A slightly lower oral intake was seen in group B than in group A. It seems likely that two main factors are responsible: the volume and the shape of the remnant stomach, because a decreased residual volume will cause microgastria (because of the small gastric remnant) [17] [18] [19] and a decrease in the exocrine function of the fundus, because a broad segmentectomy can be detrimental to the secretion of pepsin, hydrochloric acid, and ghrelin [25] [26] [27] . These factors should be considered when determining the optimal proximal transection line.
In the present study, we got comparable results in groups A and B (with patients with a 3-cm pyloric cuff being classifi ed in group B). Our comparison did not show any signifi cant differences between the two groups. It seems that there may be complex factors, such as neural damage and inadequate blood fl ow to the pylorus, or the setting of the proximal transaction line.
Finally, an accurate functional assessment of pyloric motility should be performed preoperatively as well as postoperatively, using methods such as questionnaire surveys, hormone mediated response assays, contrast studies, or scintigraphy, because postoperative gastric function is closely related to preoperative function [28] [29] [30] , and appropriate patient counseling regarding likely functional outcomes can then be undertaken.
In recent years, EGC has been estimated to account for more than 50% of all gastric cancers in Japan [31] . Endoscopic mucosal resection (EMR) is one of the accepted treatments for differentiated intramucosal cancers which arise from intestinal metaplasia and are associated with a minimal risk of regional lymph node metastasis and are seen mostly in the pyloric antrum [9] . Advanced endoscopic therapy in modern times has led to a decrease in the population receiving surgery for EGC in the lower part of the stomach, so that PPG is increasingly being performed in a relatively higher proportion of EGCs located in the middle stomach. The gender difference between the two groups in our study could be said to be a sign that the surgical therapeutic objective had shifted from the lower part to the middle part of the stomach. Therefore, an important issue is whether the scope of indications for PPG can be widened to include EGCs located high in the middle body. Whether EGC located high in the middle body is a candidate for PPG requires careful consideration, because the small capacity of the residual stomach in such cases may restrict food intake [30, 32, 33] . The postoperative outcomes in the present study were unaffected by the length of the retained antrum. PPG is a feasible procedure for the treatment of EGC even if the tumors are located in the proximal to middle body. Over the long term, an extreme reduction in the residual volume may result in microgastria, although patients seldom experience dumping symptoms.
